34 results
6-K
EX-99
BLRX
Bioline Rx Ltd
20 Nov 23
BioLineRx Reports Third Quarter 2023 Financial Results and Recent Corporate
7:03am
within the State of Israel. These attacks resulted in thousands of deaths and injuries, and Hamas additionally kidnapped many Israeli civilians
6-K
EX-99
BLRX
Bioline Rx Ltd
15 Aug 12
BioLineRx Reports Second Quarter 2012 Results
12:00am
and commercialize BL-1040 for use in the prevention, mitigation and treatment of injuries to the myocardial tissue of the heart. Under the arrangement
6-K
EX-99
BLRX
Bioline Rx Ltd
28 Nov 11
BioLineRx Reports Third Quarter 2011 Financial Results
12:00am
and treatment of injuries to the myocardial tissue of the heart. Under the arrangement, Ikaria is obligated to use commercially reasonable efforts
6-K
EX-99
BLRX
Bioline Rx Ltd
7 May 13
BioLineRx Reports First Quarter 2013 Results
12:00am
of injuries to the myocardial tissue of the heart following AMI. Under the arrangement, Ikaria is obligated to use commercially reasonable efforts to complete
6-K
EX-99
BLRX
Bioline Rx Ltd
22 May 18
BioLineRx Reports First Quarter 2018 Financial Results
7:00am
BL-1040 for use in the prevention, mitigation and treatment of injuries to the myocardial tissue of the heart. Under the arrangement, Bellerophon
6-K
EX-99
mse9ks44bkq94kczi1d7
6 Aug 13
BioLineRx Reports Second Quarter 2013 Results
12:00am
6-K
EX-99
jtxl38j4eo4
20 May 14
BioLineRx Reports First Quarter 2014 Financial Results
12:00am
6-K
EX-99
iupen3xrbj9b2bhr1
8 Nov 18
BioLineRx Reports Significant Progress Across Oncology
7:00am
6-K
EX-99
vdf3b2 wv0wxsc2faa
10 Nov 14
BioLineRx Reports Third Quarter 2014 Financial Results
12:00am
6-K
EX-99
nd88de3havo7kgt
6 Aug 14
BioLineRx Reports Second Quarter 2014 Financial Results
12:00am
6-K
EX-99
5im902qasucqp
13 Aug 18
BioLineRx Reports Second Quarter 2018 Financial Results
7:01am
6-K
EX-99
r32y7m2p6d b8ja3
20 Nov 23
BioLineRx Reports Third Quarter 2023 Financial Results and Recent Corporate
7:03am
6-K
EX-10.1
kgz wqdpk1i
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
6-K
EX-99.2
1zt8nr7g
16 Feb 12
Current Report, Foreign Issuer
12:00am
F-3
mff7la
29 Dec 23
Shelf registration (foreign)
4:15pm
424B5
0j3twppwyho6o82j0
1 Apr 24
Prospectus supplement for primary offering
10:30am
20FR12B
EX-4.17
dlm8vz2 j8
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
F-1
EX-10.17
ke4dsgll
24 Sep 10
Registration statement (foreign)
12:00am